Laryngeal Chondrosarcoma

Laryngeal chondrosarcoma is a rare, malignant cancer of the larynx and associated cartilage, most commonly affecting adults in the fifth to seventh decades of life. It is associated with a high metastatic potential, with a considerable risk of death due to local recurrence or metastasis. Treatment involves surgical resection as well as radiotherapy, chemotherapy and immunotherapy, depending on the stage of the disease. Therefore, early diagnosis and treatment is important to improve prognosis and to prevent further risk of metastasis. The importance of early recognition and referrals for this rare malignancy cannot be understated, as it is the most influential factor for the overall outcome of the disease.

← Journal of Otolaryngology Advances

Related Articles

3 article(s) found

Laryngeal Tissue Engineering using Rabbit Adipose Derived Stem Cells in Fibrin: A Pre-Clinical Model

Full-text HTML Download PDF Download XML

The Silver, Cobalt, Chromium, Iron, Mercury, Rubidium, Antimony, Selenium, and Zinc Contents in Human Bone Affected by Chondrosarcoma

Full-text HTML Download PDF Download XML

Left Brachiocephalic Vessel Venous Tumor Thrombus in a Laryngeal Cancer Patient Detected with PET-CT Imaging

Full-text HTML Download PDF Download XML